Patterns of lipid lowering therapy among children ages 8-20 years

Journal of Pediatrics

Volumn 167, Issue 1, 2015, Pages 113-119.e1

  Joyce, Nina ^a   Wellenius, Gregory A ^a   Dore, David D ^a,b   Newburger, Jane W ^c   Zachariah, Justin P ^c  

^a BROWN UNIVERSITY   (United States)

^b OPTUM   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; BILE ACID SEQUESTRANT; EZETIMIBE; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICOTINIC ACID;

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CHILD; CHRONIC INFLAMMATORY DISEASE; CHRONIC KIDNEY DISEASE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DISORDERS OF LIPID METABOLISM; DYSLIPIDEMIA; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; HYPERTENSION; INCIDENCE; INFLAMMATORY DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT; PRACTICE GUIDELINE; PREDICTOR VARIABLE; PRESCRIPTION; PRIORITY JOURNAL; AGE; AMBULATORY CARE; DIABETES MELLITUS; DYSLIPIDEMIAS; FACTUAL DATABASE; HYPERLIPOPROTEINEMIA TYPE II; INSURANCE; OBESITY; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; UNITED STATES; UTILIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AMBULATORY CARE; CASE-CONTROL STUDIES; CHILD; DATABASES, FACTUAL; DIABETES MELLITUS; DRUG PRESCRIPTIONS; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; HYPERTENSION; HYPOLIPIDEMIC AGENTS; INSURANCE CLAIM REVIEW; MALE; OBESITY; SEX FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84937523234     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2015.04.004     Document Type: Article

References (34)

1. S.R. Daniels, and F.R. Greer Lipid screening and cardiovascular health in childhood Pediatrics 122 2008 198 208
2. W.P. Newman III, D.S. Freedman, A.W. Voors, P.D. Gard, S.R. Srinivasan, J.L. Cresanta, and et al. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study N Engl J Med 314 1986 138 144
3. G.S. Berenson, S.R. Srinivasan, W. Bao, W.P. Newman III, R.E. Tracy, and W.A. Wattigney Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study N Engl J Med 338 1998 1650 1656
4. H.C. McGill Jr., C.A. McMahan, A.W. Zieske, G.T. Malcom, R.E. Tracy, and J.P. Strong Effects of nonlipid risk factors on atherosclerosis in youth with a favorable lipoprotein profile Circulation 103 2001 1546 1550
5. H.C. Knipscheer, C.C. Boelen, J.J. Kastelein, D.E. van Diermen, B.E. Groenemeijer, A. van den Ende, and et al. Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia Pediatr Res 39 1996 867 871
6. J. Rodenburg, M.N. Vissers, A. Wiegman, A.S. van Trotsenburg, A. van der Graaf, E. de Groot, and et al. Statin treatment in children with familial hypercholesterolemia: the younger, the better Circulation 116 2007 664 668
7. A. Wiegman, B.A. Hutten, E. de Groot, J. Rodenburg, H.D. Bakker, H.R. Buller, and et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial JAMA 292 2004 331 337
8. E.A. Stein, D.R. Illingworth, P.O. Kwiterovich Jr., C.A. Liacouras, M.A. Siimes, M.S. Jacobson, and et al. Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial JAMA 281 1999 137 144
9. S.B. Clauss, K.W. Holmes, P. Hopkins, E. Stein, M. Cho, A. Tate, and et al. Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia Pediatrics 116 2005 682 688
10. S. de Jongh, L. Ose, T. Szamosi, C. Gagne, M. Lambert, R. Scott, and et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin Circulation 106 2002 2231 2237
11. A. Vuorio, J. Kuoppala, P.T. Kovanen, S.E. Humphries, T. Strandberg, S. Tonstad, and et al. Statins for children with familial hypercholesterolemia Cochrane Database Syst Rev 7 2010 CD006401
12. B.W. McCrindle, L. Ose, and A.D. Marais Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial J Pediatr 143 2003 74 80
13. B.W. McCrindle Familial hypercholesterolemia in children and adolescents Curr Opin Lipidol 23 2012 525 531
14. D.M. Kusters, H.J. Avis, E. de Groot, F.A. Wijburg, J.J. Kastelein, A. Wiegman, and et al. Ten-year follow-up after initiation of statin therapy in children with familial hypercholesterolemia JAMA 312 2014 1055 1057
15. American Academy of Pediatrics Committee on Nutrition. Cholesterol in childhood Pediatrics 101 1998 141 147
16. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report Pediatrics 128 Suppl 5 2011 S213 S256
17. B.M. Psaty, and F.P. Rivara Universal screening and drug treatment of dyslipidemia in children and adolescents JAMA 307 2012 257 258
18. T. Lasky Statin use in children in the United States Pediatrics 122 2008 1406 1408 author reply 8
19. J.N. Liberman, J.E. Berger, and M. Lewis Prevalence of antihypertensive, antidiabetic, and dyslipidemic prescription medication use among children and adolescents Arch Pediatr Adolesc Med 163 2009 357 364
20. R.E. Kavey, V. Allada, S.R. Daniels, L.L. Hayman, B.W. McCrindle, J.W. Newburger, and et al. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research J Cardiovasc Nurs 22 2007 218 253
21. S.M. Brunelli, J.J. Gagne, K.F. Huybrechts, S.V. Wang, A.R. Patrick, K.J. Rothman, and et al. Estimation using all available covariate information versus a fixed look-back window for dichotomous covariates Pharmacoepidemiol Drug Saf 22 2013 542 550
22. A.B. Dart, P.J. Martens, E.A. Sellers, M.D. Brownell, C. Rigatto, and H.J. Dean Validation of a pediatric diabetes case definition using administrative health data in Manitoba, Canada Diabetes Care 34 2011 898 903
23. J.P. Vandenbroucke, and N. Pearce Case-control studies: basic concepts Int J Epidemiol 41 2012 1480 1489
24. B.W. McCrindle, P.N. Tyrrell, and R.E. Kavey Will obesity increase the proportion of children and adolescents recommended for a statin? Circulation 128 2013 2162 2165
25. S. Schneeweiss, and J. Avorn A review of uses of health care utilization databases for epidemiologic research on therapeutics J Clin Epidemiol 58 2005 323 337
26. C. Feudtner, D. Dai, K.R. Hexem, X. Luan, and T.A. Metjian Prevalence of polypharmacy exposure among hospitalized children in the United States Arch Pediatr Adolesc Med 166 2012 9 16
27. D.B. Dixon, A.P. Kornblum, L.M. Steffen, X. Zhou, and J. Steinberger Implementation of lipid screening guidelines in children by primary pediatric providers J Pediatr 164 2014 572 576
28. H.J. Avis, D.M. Kusters, M.N. Vissers, R. Huijgen, T.H. Janssen, A. Wiegman, and et al. Follow-up of children diagnosed with familial hypercholesterolemia in a national genetic screening program J Pediatr 161 2012 99 103
29. C. Baigent, L. Blackwell, J. Emberson, L.E. Holland, C. Reith, N. Bhala, and et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials Lancet 376 2010 1670 1681
30. M. Lambert, P.J. Lupien, C. Gagne, E. Levy, S. Blaichman, S. Langlois, and et al. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group Pediatrics 97 1996 619 628
31. S. de Ferranti, and D.S. Ludwig Storm over statins - the controversy surrounding pharmacologic treatment of children N Engl J Med 359 2008 1309 1312
32. J. Loughlin, S. Quinn, E. Rivero, J. Wong, J. Huang, J. Kralstein, and et al. Tegaserod and the risk of cardiovascular ischemic events: an observational cohort study J Cardiovasc Pharmacol Ther 15 2010 151 157
33. D.D. Dore, N. Ziyadeh, B. Cai, C.R. Clifford, H. Norman, and J.D. Seeger A cross-sectional study of the identification of prevalent asthma and chronic obstructive pulmonary disease among initiators of long-acting beta-agonists in health insurance claims data BMC Pulm Med 14 2014 47
34. S.R. Vinci, S.L. Rifas-Shiman, J.K. Cheng, R.C. Mannix, M.W. Gillman, and S.D. de Ferranti Cholesterol testing among children and adolescents during health visits JAMA 311 2014 1804 1807